Skip to main content
. 2023 Aug 15;15(8):5389–5407.

Table 1.

Clinical variables-wise categorization of the BRCA cohort analyzed via UALCAN

Sr. No Clinical variable Samples count per variable Total samples count Sample count having missing details Final sample count subjected to analysis
1 Cancer stage
    Stage 1 n, 183 n, 32 n, 1065
    Stage 2 n, 615
    Stage 3 n, 247
    Stage 4 n, 20
2 Age
    years = 21-40 n, 97 n, 1097 n, 10 n, 1087
    years = 41-60 n, 505
    years = 61-80 n, 431
    years = 81-100 n, 54
3 Geographical distribution
    Caucasian n, 748 n, 109 n, 988
    African-American n, 179
    Asian n, 61
4 TP53 mutation status
    TP53-Mutatnt n, 334 n, 65 n, 1032
    TP53-NonMutant n, 698

BRCA = Breast Cancer, UALCAN = University of ALabama at Birmingham CANcer.